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Sodium retention in rats with liver cirrhosis is associated with
increased renal abundance of NaCl cotransporter (NCC)
Zhenrong Yu1, Andreas Serra1, Daniel Sauter2, Johannes Lofﬁng2, Daniel Ackermann1, Felix J. Frey1,
Brigitte M. Frey1 and Bruno Vogt1
1Division of Nephrology and Hypertension, University Hospital Inselspital, Berne, Switzerland and 2Institute of Anatomy,
University of Zu¨rich, Zu¨rich, Switzerland
Abstract
Background. Liver cirrhosis is associated with
enhanced renal tubular sodium retention, the mecha-
nism of which is still debated. We hypothesized that
liver cirrhosis is associated with increased expression
of renal epithelial sodium transporter(s).
Methods. Liver cirrhosis was induced by bile duct
ligation (BDL) in rats. Steady state mRNA of
ENaC subunits a, b, g serum and glucocorticoid
inducible kinase (Sgk1) were measured by TaqMan
PCR in kidney homogenates at week 1, 2, 3 and
4 after BDL. Renal protein content of ENaC
subunits, ubiquitin-protein-ligase Nedd4-2 and NaCl
cotransporter (NCC) were assessed by western blot.
Subcellular localization of ENaC subunits and NCC
were analysed by immunohistochemistry.
Results. Steady state mRNA of ENaC a, b and g
were unchanged during the 4 weeks investigated,
while ENaC protein decreased most prominently at
week 2 (control vs BDL; a, 46%; b, 81%; and g,
63%; n¼ 6). Subcellular localization of ENaC
subunits was not altered at week 2. Sgk1 mRNA did
not change, whereas Nedd4-2 protein was reduced
by >50% 2–4 weeks after BDL. NCC protein
signiﬁcantly increased at week 1 (control vs BDL:
þ66%, n¼ 6, P<0.05) and decreased at week 3
(control vs BDL: 85%, n¼ 6, P<0.0005).
Conclusions. Enhanced abundance of NCC was
observed in the initial stage after BDL, followed by
a marked decrease. ENaC transcription, translation
or cell surface abundance was not increased after BDL.
Keywords: epithelial sodium channel (ENaC);
bile duct ligation (BDL); liver cirrhosis;
Na-Cl cotransporter (NCC); Nedd4-2;
serum glucocorticoid inducible kinase 1 (Sgk1)
Introduction
Regulation of renal sodium excretion is crucial for
maintaining extracellular ﬂuid (ECF) volume within
normal limits. Any manoeuvre that increases ECF
volume causes a prompt and sustained natriuresis
until volume returns to normal. This homeostatic
mechanism is disturbed in patients with liver cirrhosis;
enhanced renal salt retention increases ECF volume,
contributing to the formation of oedema and ascites.
The aldosterone sensitive distal tubule (ASDN)
of the kidney, comprising at least the late part of the
distal convoluted tubule (DCT), the connecting tubule
(CNT) and the cortical as well as the medullary
collecting duct (CCD andMCD, respectively) is central
for the regulation of ECF volume in many disease
states [2]. With respect to liver cirrhosis, several lines of
evidence suggest that the ASDN is the key segment
involved in enhanced renal sodium retention and
potassium loss. For example, it is well established in
clinical practice that the mineralocorticoid receptor
antagonist spironolactone with its primary action in
the ASDN restores ECF volume in patients with liver
cirrhosis [3]. From experimental studies it has become
clear that various mechanisms explaining enhanced
renal avidity of sodium in the cirrhotic disease state
are most likely located in the ASDN. Increased
concentrations of ligands accounting for enhanced
mineralocorticoid receptor (MR) activation in CCD
in liver cirrhosis have been reported. In some animal
models and humans with cirrhosis, aldosterone levels
were found to be increased and/or the access of cortisol
to the MR enhanced, due to a bile acid-mediated
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inhibition of the enzyme 11b-hydroxysteroid dehydro-
genase type 2 (11b-HSD2), the gate-keeper enzyme for
MR activation by the glucocorticoid cortisol [4–6].
Taken together, these ﬁndings suggest that renal
tubular mechanisms are responsible for sodium reten-
tion, which mainly occur at the ASDN, the site of
action of mineralocorticoid hormones.
The rate-limiting factor of vectorial sodium transport
induced by MR-activating ligands in the ASDN is the
induction of the amiloride-sensitive sodium channel
(ENaC) [2]. This channel is composed of homologous
2a, 1b and 1g subunits. Serum glucocorticoid-inducible
kinase (Sgk1) causes an increase in ENaC channels
at the cell surface, is induced by aldosterone and
appears to be a primary mediator of aldosterone
action. ENaC clearance at the cell surface is regulated
by ubiquitylation mainly through the ubiquitin-protein
ligase Nedd4-2, a negative regulator of ENaC. Sgk1
phosphorylates Nedd4-2 and by this mechanism
impairs the interaction between Nedd4-2 and ENaC,
leading to elevated ENaC cell surface expression and
increased sodium absorption [7].
The thiazide-sensitive NaCl cotransporter (NCC),
which is expressed on the apical membrane of epithelial
cells lining the distal convoluted tubule, is responsible
for the reabsorption of at least 3% of the ﬁltered
load of sodium. Evidence for a regulatory action of
the mineralocorticoid hormone aldosterone on NCC
comes from several observations in whole-animal
studies [8]. Enhanced MR activation might increase
NCC expression and/or NCC sensitive sodium uptake
and contribute to renal sodium retention in liver
cirrhosis.
The aim of the present study was to investigate
the impact of liver cirrhosis induced by bile duct
ligation on the renal expression of ENaC, on the ENaC
regulating proteins, and on NCC.
Methods
Experimental animals
Male Sprague-Dawley rats (200–220 g body wt) were
maintained on standard laboratory chow and tap water
with a 12 h light/dark cycle at a constant temperature and
humidity. The animal work was undertaken according to the
Swiss national legislation governing the use of animals and
the committee on animal research at the University of Berne.
We used bile duct excision to produce cirrhosis as in
previous investigations [4]. All bile duct ligated animals had
coarsely granular livers and portal hypertension by macro-
scopic inspection. Animals were allotted to bile duct excision
(n¼ 24) or sham surgery (n¼ 24). After an adaptation period
of 7 days, animals were anaesthetized with ketamine
(75mg/kg body weight) and xylazine (5mg/kg body weight)
administered subcutaneously and a 2 cm upper abdominal
midline incision was made. In the experimental group, the
bile duct was isolated and a 0.5 cm section was excised after a
double ligation. In the sham group, the bowel and mesentery
were manipulated and replaced. After 1, 2, 3 and 4 weeks,
six animals per group were anaesthetized, kidneys removed,
and immediately frozen in liquid nitrogen and stored
at 80C. Tissues were powdered with a mortar and pestle
in a mixture of dry ice and acetone before being used
for RNA extraction. Half of each kidney was ﬁxed for
immunohistochemistry [9].
Metabolic studies and plasma aldosterone
Plasma aldosterone concentrations were determined by a
radioimmunoassay (Iodine-125 tracer, Coat-A-Count;
Diagnostic Products Corporation, Los Angeles CA). Serum
and urine creatinine was determined on a Hitachi 917
autoanalyser (Roche, Basel, Switzerland) according to a
modiﬁed Jaffe´ method. Creatinine clearance was calculated
by the standard formula UcreatVurine / Pcreat (Ucreat, creati-
nine concentration in urine; Vurine, volume of urine in 24 h
collection; Pcreat, plasma concentration of creatinine).
RNA extraction
Kidneys were homogenized in RNA extraction buffer using
a Polytron. Total RNA was extracted according to the
method of Chomczynski and Sacchi with minor modiﬁca-
tions: the RNA pellet resulting from the ﬁrst precipitation
was resuspended in DEPC-treated water, and 0.1 vol of 2M
sodium acetate and 1 vol of phenol pH 4.0 were added
sequentially [10]. The suspension was vortexed, centrifuged
at 10 000 g for 20min, and the upper phase precipitated with
isopropanol at 20C for 1 h.
Reverse transcription
Reverse transcription (RT) was performed using 2mg of
total RNA in a ﬁnal volume of 20ml. RNA was incubated
with 500 ng of oligo(dT) primer at 65C for 5min, followed
by incubation at room temperature for 15min. Samples
were then incubated with 250mM deoxynucleotide triphos-
phates, 20U of RNase-Inhibitor, and 25U of AMV reverse
transcriptase (Roche, Rotkreuz, Switzerland) in 1buffer
(50mM Tris–HCl, 40mM MgCl2, 30mM KCl, 1mM DDT,
pH 8.5) at 42C for 1 h. For control reactions (RT–), enzymes
were replaced by DEPC-treated-water.
Real-time PCR
Primers (Microsynth, Balgach, Switzerland) and TaqMan
probes (Applied Biosystems, Rotkreuz, Switzerland)
unique for each rat isoform were designed, optimized
and validated: 50-ctgccaagtatgatgacatcaagaa (GAPDH);
30-agcccaggatgccctttagt (GAPDH); 50-cagggtgatggtgcatggt
(a-ENaC); 30-ccacgccaggcctcaag (a-ENaC); 50-cataatcctag
cctgtctgtttgga (b-ENaC); 30-cagttgccataatcagggtagaaga
(b-ENaC); 50-tgcaagcaatcctgtagctttaag (g-ENaC); 30-gaagcc
tcagacggccatt (g-ENaC); 50-gagggagcgctgcttcct (Sgk1);
30-acccaaggcactggctatttc (Sgk1). These probes were used
for GAPDH (tcggccgcctgcttcacca); a-ENaC (tgaagccaccat
catccataaaggcag); b-ENaC (ccctgcagtcatcggaacttcacacct);
g-ENaC (aatggacactgaccaccagcttggc); Sgk1 (ccccgtgctcgctt
ctacgca). Real-time quantitative TaqMan PCR was per-
formed by ABI PRISM 7700 Sequence Detection System.
Diluted RT samples (10 ng of total RNA) were ampliﬁed
in a ﬁnal volume of 25ml. Primers were used at a
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concentration of 200 nM, probes (FAM/TAMRA labelled) at
a concentration of 100 nM except for gENaC for which the
probe concentration was 200 nM. GAPDH was used as a
housekeeping gene and ampliﬁed in separate reactions.
RTþ reactions were performed in triplicate, RT– in duplicate.
The thermal cycling conditions were as follows: 50C for
2min, 95C for 10min, followed by 40 cycles of 95C for 15 s
and 60C for 1min.
Western blots
Sucrose buffer containing 250mM sucrose, 1mg/ml leupeptin
(Sigma, St Louis, MO), 10mM triethanolamine (Merck,
Germany) and 0.1mg/ml PMSF (Calbiochem, Germany), pH
7.6 was freshly prepared. Frozen powdered kidney tissue was
homogenized in cold sucrose buffer using FastPROTEIN
GREEN tubes (Lysing Matrix D, Q-Biogene, Alexis Corp,
Lausanne, Switzerland) and a BIO 101 Savant FastPrep
FP120 device (Q-Biogene) at a speed of 4.0U for 20 s. The
homogenized tissue was centrifuged at 4C, 3600 r.p.m. for
10min. The supernatant was kept on ice and the pellet,
dissolved in sucrose buffer, was centrifuged at the same speed
again. The second supernatant was pooled with the ﬁrst
supernatant and the protein concentration determined using
the BCA kit (Pierce BCA Protein Assay Reagent Kit, Pierce).
From each sample 30mg of protein was incubated with
La¨mmli buffer at 37C for 30min and then immediately
loaded onto 8 or 10% polyacrylamide gels. Proteins were
transferred from the gels to PVDF membranes (Immobilon,
Millipore Corp, Bedford, MA). Blots were blocked with 5%
non-fat milk at room temperature for 90min and incubated
with the appropriate afﬁnity-puriﬁed polyclonal antibody
overnight at 4C (see below). The secondary antibody
conjugated to horseradish peroxidase was a rabbit anti-
chicken/turkey IgG for bENaC (Zymed, CA, USA) protein
and a swine anti-rabbit IgG (DAKO, Denmark) for aENaC,
gENaC and NCC. Antibody binding was visualized by
enhanced chemoluminescence (ECL; Amersham Pharmacia
Biotech, UK). The densitometry of the individual bands was
performed using the Scion Image software. The quantiﬁed
data of western blots are expressed as arbitrary units divided
by their respective GHPDA signal. GAPDH was used as
loading control and remained stable over the study period
[which was not the case of b-actine (results not shown)].
Afﬁnity-puriﬁed rabbit antibody against aENaC was a gift
fromDr L.Dijkink (Universiteit Nijmegen, TheNetherlands),
the rabbit antibody against gENaC fromDrNicolette Farman
(INSERM U478, Paris, France). The antibody against
bENaC was raised in chicken using the peptide (amino
acids 46–68) NH2-CNYDSLRLQPLDTMESDSEVEAI
(Davids Biotechnology, Regensburg, Germany) [11].
Nedd4-2 antibody was made by O. Staub, University of
Lausanne, Switzerland [12]. NCC antibody was obtained
from J. Lofﬁng [13].
Immunohistochemistry
Kidney ﬁxation and immunohistochemistry for ENaC were
performed at weeks 1 and 2 as described [9]. For detection
of ENaC, we used a set of newly generated rabbit anti-
rat ENaC antibodies that were kindly provided by Dr
B. Rossier, University of Lausanne, Switzerland. Serial
cryosections were stained with the anti-rat aENaC
antiserum diluted 1:1000, the anti-rat bENaC antiserum
diluted 1/500, the anti-rat gENaC antiserum diluted 1:400,
and the anti-rabbit NCC diluted 1/1000 antiserum. Binding
sites of the primary antibodies were detected with
Cy3-conjugated donkey anti-rabbit IgG (Jackson Immuno
Research Laboratories, West Grove, PA), diluted 1/1000
[13]. All antibodies were diluted in PBS/BSA 1%. For
control of unspeciﬁc antibody binding, the primary
antibodies were omitted or replaced by a non-immune
rabbit serum. Immunostainings were evaluated by two
investigators blinded for the treatment group of the
animals. Both investigators came independently to the
same conclusions concerning the subcellular localization
and quantitatively assessed immunostaining intensities for
the analysed proteins.
Statistics
Statistical analyses were performed with SYSTAT 10.0 for
Windows (SPSS INC, Chicago, IL) for non-parametric data
(Mann–Whitney). Two-way ANOVA was used to determine
the effect of time and treatment with BDL on measured
parameters. Results are presented as mean±SD.
Results
Metabolic studies and plasma aldosterone
concentrations
At week 1, jaundice was present in the BDL animals
and at week 3 these animals showed clear signs of ascite
formation. Body weight increased at week 4 when
compared to the sham operated animals (Table 1).
Sodium retention was observed at weeks 1 and 4 with
no signiﬁcant reduction in renal function (Table 2).
Plasma aldosterone concentrations were unchanged in
BDL rats when compared to control animals at weeks
1–4 (control vs BDL: week 1, 482±52 vs 416±70 pM;
week 2, 884±188 vs 841±191 pM; week 3, 748±142 vs
620±149 pM; week 4, 498±95 vs 671±105 pM; n¼ 6
in each group, P ¼ NS for each week).
mRNA expression and protein amount of ENaC
Expression of a, b and gENaC mRNAs in the kidneys
of BDL rats did not change throughout the 4 week
study period (results not shown). Abundance of a, b
and gENaC protein was decreased in BDL rats at
week1 (control vsBDL:a,24±11%;b,42±9%;and
g, 52±12%; n¼ 6; P<0.001); this decrease was more
Table 1. Body weight of control and BDL rats at weeks 0–4 before
and after bile duct excisions
Body weight Week 0 Week 1 Week 2 Week 3 Week 4
Control 221±9 238±9 243±9 254±13 259±11
BDL 223±8 234±7 249±5 252±11 269±14
Control vs BDL: weeks 0–3, P¼NS; week 4, P<0.003.
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pronounced at week 2 (control vs BDL: a, 46±42%;
b, 81±13%; and g, 63±18%; n¼ 6; P<0.001)
and at week 4 (control vs BDL: a, 51±20%; b,
73±18%; and g, 55±20%; n¼ 6; P<0.001)
(Figure 1). ANOVA analysis for aENaC protein
revealed no difference between the BDL groups at
different time points, for bENaC BDL the group
from week 2 was different when compared to week 1
(F¼ 9.814; P<0.0035), but not different to BDL at
week 4. For gENaC, BDL of week 3 is more decreased
compared to week 1 (F¼ 9.705; P<0.004).
Sgk1 and NCC mRNA expression. Protein amount
of Nedd4-2 and NCC
Steady state levels of Sgk1mRNA were not different
in BDL rats and in sham operated animals (results not
shown). Nedd4-2 protein content decreased during
the study period with the most prominent decline at
week 2 (control vs BDL: 65±22%, n¼ 6; P<0.001)
(Figure 2). The abundance of NCC was signiﬁcantly
increased in BDL compared to control at week 1
(control vs BDL: þ66±41%, n¼ 6; P<0.05) and
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Fig. 1. Protein amount of ENaC subunits in kidneys from rats with BDL-induced liver cirrhosis (black bars) and control animals
(open bars) as assessed by quantitative western blot. For each time point, n¼ 6 BDL rats were compared with n¼ 6 sham-operated
animals. Values are mean±SD; *P<0.005 and **P<0.01.
Table 2. Urinary Naþ and Kþ excretion (mmol/24 h) and creatinnine clearance (ml/min per 100 g body wt) before and after bile
duct excision
Values Control BDL
Week 0 Week 1 Week 2 Week 3 Week 4
Naþ urine 0.78 (±0.5) 0.45* (±0.5) 0.62 (±0.4) 0.63 (±0.9) 0.40* (±0.6)
Kþ urine 0.19 (±0.3) 0.15 (±0.1) 0.25 (±0.6) 0.14 (±0.2) 0.21 (±0.2)
Creatinine 0.83 (±0.1) 0.5** (±0.4) 0.6 (±0.3) 0.5 (±0.7) 0.8 (±0.3)
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decreased in BDL at week 3 when compared to control
(control vs BDL: 85%±20%, n¼ 6; P<0.0005;
Figure 3), without changes in mRNA expression
except an increase at week 4. No difference was
detected between BDL and control at weeks 2 and 4.
ANOVA analysis revealed a difference between BDL
week 1 to week 2 (F¼ 9.934; P<0.003) and between
week 1 and weeks 3 and 4, respectively (F¼ 9.705;
P<0.004).
Immunohistochemistry of ENaC and NCC
The cellular and subcellular localization of a, b and
gENaC subunits and NCC were analysed in the kidney
cortex of sham operated and BDL rats at week 1 and
at week 2 after surgery (four rats in each group). The
time point after surgery had no effect on the immuno-
staining for ENaC subunits. Therefore, results are
shown only for week 2 (Figures 4–6). In sham operated
rats, the antibody binding pattern for a, b and gENaC
subunits and NCC were comparable to those described
previously in normal rats. As shown exemplarily for
bENaC in Figure 4, ENaC was detectable in CNT
and CCD proﬁles grouped around the cortical radial
vessels or running in the medullary rays, respectively.
The analysis of the renal tissue obtained from sham
operated and BDL revealed similar ENaC distribution.
However, bENaC and gENaC (not shown) immuno-
staining in the CCDs, but not CNTs, were weaker in
BDL than in sham operated rats. Higher magniﬁca-
tion of the CNT and CCD proﬁles (Figures 5 and 6)
reveal for all groups a predominant intracellular
localization of ENaC subunits in the CNT and CCD
cells. Only for aENaC was occasionally a weak apical
immunostaining observed in some CNT proﬁles
(Figure 5). NCC was detected in DCT proﬁles located
in the renal cortex of sham operated and BDL rats.
Consistent with the western blot data, NCC-related
immunostaining was more pronounced in DCTs of
BDL than of sham operated rats at week 1, but not at
week 2 (Figure 7).
Discussion
Ascites and oedema formation in liver cirrhosis
induced by BDL in rats is due to increased renal
sodium reabsorption. The present study was designed
to investigate ENaC, the ENaC regulatory proteins
Sgk1 and Nedd4-2, and NCC in BDL rats. Following
BDL, (i) mRNA of ENaC subunits remain stable,
(ii) protein amounts of a, b and gENaC decreases,
(iii) mRNA of Sgk1 is unchanged, (iv) subcellular
distribution of ENaC subunits is not altered when
analysed by immunohistochemistry despite decreased
expression of Nedd4-2 protein, and (v) protein abun-
dance of NCC increases at week 1 when analysed by
immunoblotting and immunohistochemistry.
The protein amount of a, b and gENaC was
decreased in BDL rats despite stable mRNA expres-
sion of the corresponding ENaC subunits (Figure 1).
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induced liver cirrhosis (black bars) and control animals (open bars)
as assessed by quantitative western blot. For each time point, n¼ 6
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induced liver cirrhosis (black bars) and control animals (open bars)
as assessed by quantitative western blot. For each time point, n¼ 6
BDL rats were compared with n¼ 6 sham-operated animals. Values
are mean±SD; *P<0.005.
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Thus, it is not possible to link directly the amount of
ENaC protein with transcription. Berger et al. [14]
studied the relevance of the MR on mRNA abundance
of ENaC by using MR knockout mice. MR deﬁciency
did not affect the mRNA abundance of a, b and
gENaC subunits in the kidney of MR–/–mice, indicat-
ing that MR-mediated control of renal Naþ reabsorp-
tion was not achieved by transcriptional control of
ENaC expression [14]. Recent investigations by
Escoubet et al. [15] revealed that aldosterone depletion
had no or only a weak effect on renal a, b and gENaC
subunits mRNA expression. Our results of decreased
amounts of a, b and gENaC despite enhanced MR
activation by 11b-hydroxy-steroids in BDL rats are
in line with these observations suggesting the absence
of a direct link between MR activation and mRNA
and protein levels of ENaC subunits. Thus, other as
yet unidentiﬁed mechanisms are involved in the regu-
lation of a, b and gENaC in health and disease states
[14,15].
We measured the total amount of ENaC protein
by quantitative western blot. It is conceivable that the
pattern of intracellular distribution of ENaC subunits
is altered in the BDL-induced disease state, an effect
that would have been missed by these analyses.
An altered pattern of ENaC distribution might be
attributable to a post-transcriptional regulatory event,
either by affecting biosynthesis or stability of the ENaC
proteins.
Two proteins are interesting with respect to the
regulation of ENaC: Nedd4-2, which negatively con-
trols cell surface density of ENaC, and Sgk1, which
is an aldosterone-dependent, positive regulator of
ENaC expression [7,16]. Nedd4-2 protein amount was
decreased in weeks 1–4 in BDL rats when compared to
sham operated animals (Figure 2). Based on the role
of Nedd4-2, one might predict an increased abundance
of ENaC protein in rats with BDL, which is deﬁnitely
not the case (Figure 1). In the present study we
assessed the total amount of Nedd4-2. Thus it is still
conceivable that the amount of biologically active
Sham Operated Bile Duct Ligation
Fig. 5. Immunohistochemical detection of a, b and gENaC in
consecutive CNT proﬁles of a sham-operated rat (left panel) and a
BDL rat (right panel); consecutive cryosections immunostained
with rabbit-anti-rat a, b and gENaC antibodies followed by a Cy3-
conjugated goat-anti-rabbit IgG. ENaC subunits are diffusely
distributed throughout the cytoplasm of a subset of CNT cells.
Only aENaC is occasionally observed at the apical plasma
membrane of CNT cells. Unstained cells in CNT proﬁles represent
intercalated cells.
Sham Operated Bile Duct Ligation
Fig. 4. Immunohistochemical detection of bENaC in the renal cortex of a sham-operated rat (left panel) and a BDL rat (right panel) at
week 2; boxes, connecting tubule (CNT) and cortical collecting duct (CCD) proﬁles shown at higher magniﬁcation in Figures 5 and 6,
respectively.
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unphosphorylated Nedd4-2 was unchanged in BDL
rats and therefore ENaC did not change. Alternatively,
Nedd4-2 might have changed in kidney segments not
expressing ENaC, thus concealing a direct link between
Nedd4-2 and ENaC levels. Nedd4-2 simply affects
intracellular localization of ENaC and not the total
pool. To assess the effect of the observed down-
regulation of Nedd4-2 on the intracellular localization
of ENaC, we performed an immunohistochemical
analysis of all three ENaC subunits. Subcellular
distribution of all three subunits was not disturbed in
BDL animals when compared to the appropriate
controls, indicating that Nedd4-2 downregulation
appears to exhibit no or only a minor effect on intra-
cellular localization of ENaC in this speciﬁc disease
state (Figures 4–6). An unexplained ﬁnding is the slight,
but steadily decreasing protein abundance of Nedd4-2
in the controls (Figure 2). mRNA of Sgk1 is present in
BDL rats; however, no modulation of Sgk1 expression
assessed by steady-state mRNA measurements was
observed.
We measured a, b and gENaC mRNA and protein
in BDL rats but did not assess ENaC activity in the
CCD. One might speculate that ENaC is activated
despite the presence of normal or low amounts of
ENaC proteins. Such an activation might occur
through increased bile acid concentrations in BDL
Sham Operated Bile Duct Ligation
Fig. 6. Immunohistochemical detection of a, b and gENaC in
consecutive CCD proﬁles of a sham operated rat (left panel) and a
BDL rat (right panel); consecutive cryosections immunostained
with rabbit-anti-rat a, b and gENaC antibodies followed by a
Cy3-conjugated goat-anti-rabbit IgG. ENaC subunits are diffusely
distributed throughout the cytoplasm of a subset of CCD cells.
Unstained cells in CNT proﬁles represent intercalated cells.
Week 1
Control Ligation
Week 1
Control Ligation
Fig. 7. Immunohistochemical detection of NCC in DCT proﬁles,
sham-operated rats (left column) and BDL rats (right column) at
week 1 (upper row), and week 2 (lower row); cryosections
immunostained by rabbit-anti-rat bENaC antibody followed by
a Cy3-conjugated goat-anti-rabbit IgG. NCC is exclusively seen
in DCT located in the renal cortex. BDL slightly increases
NCC-related immunostaining in week 1, but not in week 2, when
compared to the respective sham-operated control.
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rats. Lima et al. [17] have shown that the bile acid
deoxycholate stimulates the amiloride sensitive sodium
current in frog skin. However, until the activity of
ENaC is not measured directly by electrophysiological
methods in the renal tubular segments from BDL rats
such a mechanism remains speculative.
Jonassen et al. [18] proposed the thick ascending limb
(TAL) and not the CCD to be responsible for abnormal
renal sodium retention in BDL rats. They measured
Na,K-ATPase activity at Vmax conditions in micro-
dissected tubules from TAL and outer medullary
collecting duct (OMCD) in rats 5 weeks after BDL.
Na,K-ATPase activity per mm tubule length was
decreased in the OMCD and unchanged in the TAL.
This interesting ﬁnding is not at variance with our
study because the authors considered the OMCD
and not CCD and, furthermore, the measurements
took place at a relatively late time point after BDL
(week 5) when the mineralocorticoid escape phenom-
enon is present. In addition, it has been suggested
that measurement of Na,K-ATPase at Vmax and not
at lower V might jeopardize the identiﬁcation of
dysregulations of the Na,K-ATPase activity in
disease states.
The NCC located in the apical membrane of the
DCT is responsible for the thiazide-sensitive sodium
uptake. Expression of NCC was increased 1 week after
BDL with stronger immunostaining for NCC in the
DCTs when compared to control (Figures 3 and 7).
NCC mediated sodium uptake is stimulated by
forskolin, a drug that promotes the adenylyl cyclase-
catalyzed production of cAMP, acting through PKA.
However, PKA-induced sodium uptake by activation
of NCC does not increase expression of NCC
and therefore might not account for the mechanism
of increased NCC in BDL rats. In the long term, aldo-
sterone causes a signiﬁcant increase in protein amount
of NCC and in NCC mediated sodium uptake. This
mechanism seems unlikely because the plasma aldos-
terone concentration was similar in BDL animals when
compared to the control animals. An aldosterone-
independent activation of MR has been identiﬁed in
rats with BDL and in human subjects with elevated
serum bile acids might represent a possible pathway to
activate NCC in the cirrhotic disease state.
An unexplained ﬁnding is the strong decrease in
NCC protein amount 3 weeks after BDL. A similar
observation was reported by Fernandez-Llama et al.
[19] in a model of liver cirrhosis secondary to chronic
CCl4 inhalation. The authors measured a decrease in
renal NCC protein at weeks 12–25 after starting
cirrhosis induction with CCl4. One might speculate
if this decreased NCC protein amount in BDL rats
at 3 weeks and in the chronic cirrhosis model induced
by CCl4 inhalation is not simply representing a
mineralocorticoid escape phenomenon known to
decrease substantially the NCC protein amount in the
kidney [19]. In a recent publication from Fernandez-
Llama et al. an increase in NCC protein and aENaC
was observed in the same liver cirrhosis model induced
by CCl4 inhalation. The authors relate these changes to
an aldosterone effect. The discrepancy of the different
observations is probably related to the different time
point of observation, and with regard to our study, to
the different animal model [20].
In conclusion, the expression of NCC is increased
in kidney homogenates 1 week after BDL, a ﬁnding
that might explain early renal sodium retention in
BDL induced liver disease. The expression of a, b and
gENaC subunits is decreased in kidney tissue of BDL
rats without evidence for changes in subcellular
distribution of the three ENaC subunits.
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